Calcium and bone density
This article was originally published in The Tan Sheet
Calcium supplementation beneficially affects bone density in healthy women over age 55, according to a study in the September American Journal of Medicine. The randomized controlled trial of 1,471 healthy, postmenopausal women took place over five years in New Zealand. Subjects received either 1 g of elemental calcium daily (as citrate) or identical placebo, Ian Reid, MD, et al., Department of Medicine, University of Auckland, New Zealand, state. Calcium had a significant beneficial effect on bone density with between-group differences at five years showing increases of 1.8% for the spine, 1.6% for the hip and 1.2% for the total body, researchers state. However, the beneficial effects on bone density were tempered with the "lack of a clear-cut effect of calcium on fracture rates," which may be attributed to the poor rates of long-term compliance, Reid et al. say. The study is the longest and largest calcium-only study yet published and "as such, it is able to establish the beneficial effects of calcium supplementation on bone density with greater certainty than has been possible thus far," according to Reid et al....
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.